Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Ovarian Neoplasms × cobimetinib × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumor 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Craniopharyngioma 1 Brain Neoplasms 1

Interventions

pembrolizumab 24 Paclitaxel 20 Carboplatin 20 olaparib 19 Bevacizumab 13 Magnetic Resonance Spectroscopy 11 Gemcitabine 11 Taxes 10 Nivolumab 10 Cyclophosphamide 10 niraparib 9 Specimen Handling 8 Biopsy 8 liposomal doxorubicin 5 fludarabine 5 durvalumab 5 Surveys and Questionnaires 5 Immunoglobulin G 5 Doxorubicin 5 Disulfides 5 Cisplatin 5 Letrozole 4 Ipilimumab 4 palbociclib 3 oregovomab 3 cediranib 3 atezolizumab 3 X-Rays 3 Pemetrexed 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04931342 2026-03-10

BOUQUET

Hoffmann-La Roche

Phase 2 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡